Zhejiang, China

Dongju Wang

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Beijing Migrasome Therapeutics Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dongju Wang. Retrieved from https://idiyas.com/inventor/dongju-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Dongju Wang

Introduction

Dongju Wang is a prominent inventor based in Zhejiang, China. He has made significant contributions to the field of biomedicine, particularly through his innovative work on engineered migrasomes. His research focuses on developing advanced delivery systems that can enhance therapeutic applications.

Latest Patents

Dongju Wang holds 1 patent for his invention titled "Engineered migrasome, method for preparing same, and uses thereof." This patent addresses the preparation of engineered migrasomes and their applications in biomedical delivery systems. The invention aims to improve the efficacy of drug delivery and therapeutic interventions.

Career Highlights

Wang is currently associated with Beijing Migrasome Therapeutics Limited, where he continues to advance his research in the field. His work has garnered attention for its potential to revolutionize treatment methodologies in biomedicine.

Collaborations

Dongju Wang collaborates with notable colleagues, including Li Yu and Chen Dai, who contribute to his research endeavors. Their combined expertise enhances the development of innovative solutions in the biomedical sector.

Conclusion

Dongju Wang's contributions to biomedicine through his patented innovations highlight the importance of engineered migrasomes in therapeutic applications. His ongoing work promises to pave the way for future advancements in drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…